Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.630
+0.060 (3.82%)
Nov 22, 2024, 4:00 PM EST - Market closed
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $128.92 million as of November 22, 2024. Its market cap has decreased by -31.90% in one year.
Market Cap
128.92M
Enterprise Value
70.40M
1-Year Change
-31.90%
Ranking
Category
Stock Price
$1.63
Market Cap Chart
Since April 25, 2013, Innate Pharma's market cap has increased from $125.22M to $128.92M, an increase of 2.95%. That is a compound annual growth rate of 0.25%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TriSalus Life Sciences | 138.12M |
| Vaxart | 136.46M |
| Seres Therapeutics | 130.82M |
| Ventyx Biosciences | 130.81M |
| Vigil Neuroscience | 130.26M |
| Cardiol Therapeutics | 127.09M |
| Zomedica | 126.90M |
| Compugen | 126.25M |